NLG919: Potent IDO Inhibitor for Cancer Immunotherapy | Manufacturer & Supplier
Explore NLG919 (CAS: 1402836-58-1), a leading indoleamine-2,3-dioxygenase (IDO) pathway inhibitor. Discover its critical role in combating cancer-associated immunosuppression and enhancing T cell responses. Your trusted manufacturer and supplier for advanced pharmaceutical intermediates.
Get a Quote & SampleUnlock the Power of Immunotherapy with NLG919
NLG919
As a premier manufacturer and supplier of pharmaceutical intermediates in China, we offer NLG919 (CAS: 1402836-58-1), a highly potent indoleamine-2,3-dioxygenase (IDO) pathway inhibitor. This compound is crucial for research into cancer immunotherapy, effectively combating immunosuppression by inhibiting IDO-induced T cell suppression and restoring T cell activity. Purchase high-quality NLG919 for your innovative research and development needs.
- Potent IDO Pathway Inhibition: Exhibiting low nanomolar Ki and EC50 values, our NLG919 manufacturer ensures superior efficacy in blocking the IDO pathway.
- Restoration of T Cell Response: Essential for reversing immunosuppression, this IDO inhibitor is key for researchers looking to buy for studies in cell-based assays.
- In Vivo Efficacy: Demonstrates significant tumor volume reduction when combined with T cell vaccines, making it a valuable compound for purchase.
- Key Pharmaceutical Intermediate: A critical component for developing novel cancer treatments, readily available from our supplier.
Advantages of Sourcing NLG919
Uncompromised Purity and Quality
Our commitment as a leading manufacturer ensures that every batch of NLG919 (CAS: 1402836-58-1) meets stringent purity standards, guaranteeing reliable results for your research. Buy with confidence from a trusted supplier.
Competitive Pricing & Availability
We offer competitive price points for NLG919, making this vital IDO inhibitor accessible for a wide range of research budgets. Inquire about bulk purchase discounts from our China-based supplier.
Expert Technical Support
Leverage our deep expertise as a specialized pharmaceutical intermediate supplier. We provide comprehensive support to assist you in effectively utilizing NLG919 for your specific applications.
Applications of NLG919 in Research & Development
Cancer Immunotherapy Development
NLG919 is a critical pharmaceutical intermediate for developing next-generation cancer immunotherapies, aiming to overcome tumor-induced immune suppression. Researchers can purchase NLG919 for preclinical and clinical studies.
Immunomodulatory Drug Discovery
As a potent IDO inhibitor, NLG919 is invaluable for discovering and optimizing immunomodulatory drugs targeting the kynurenine pathway. Explore its potential by inquiring about our supplier's offerings.
In Vitro and In Vivo Studies
Its proven ability to inhibit T cell suppression in vitro and reduce tumor volume in vivo makes NLG919 (CAS: 1402836-58-1) a versatile tool for researchers worldwide. Buy high-quality samples today.
Research on Autoimmune Diseases
Beyond cancer, NLG919's role in immune regulation makes it a subject of interest for research into autoimmune disorders where immune tolerance needs to be restored. Contact our manufacturer for purchase details.